Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Salehi's team and collaborators at Stanford included Van Dang, DVM, PhD, a postdoctoral scholar in psychiatry and behavioral sciences; Rachel Nosheny, PhD, a postdoctoral scholar in molecular and cellular physiology; and John Wesson Ashford, MD, PhD, a clinical professor of psychiatry and behavioral sciences. All researchers except Nosheny are affiliated with both the Stanford University School of Medicine and the Veterans Affairs Palo Alto Health Care System.
The study was funded by grants from the Down Syndrome Research and Treatment Foundation and Research Down Syndrome. Stanford University has filed a patent for the use of beta-2 adrenergic receptor agonists in Down syndrome.
Stanford University Medical Center
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Pediatrics / Children's Health category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Stanford University Medical Center. "In Mouse Model Of Down Syndrome, Formoterol Improves Cognitive Function." Medical News Today. MediLexicon, Intl., 4 Jul. 2013. Web.
24 Apr. 2014. <http://www.medicalnewstoday.com/releases/262829>
Stanford University Medical Center. (2013, July 4). "In Mouse Model Of Down Syndrome, Formoterol Improves Cognitive Function." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/262829.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT is the registered trade mark of MediLexicon International Limited.